MIR

EX-99.1

2 a2026-07x28exhibit991.htm

EX-99.1

Document

Exhibit 99.1

News Release

Mirion Announces Second Quarter 2026 Financial Results

•Revenues for the second quarter increased 19.7% to $266.8 million, compared to $222.9 million in the same period in 2025.

•GAAP net income was $8.1 million in the second quarter, a 4.7% decrease compared to GAAP net income of $8.5 million in the same period in 2025; Adjusted EBITDA was $65.3 million in the second quarter, a 27.5% increase from $51.2 million in the same period last year.

•GAAP net earnings per share in the second quarter was $0.03, compared to $0.04 in the same period in 2025. Adjusted earnings per share for the quarter was $0.12, compared to $0.11 in the same period in 2025. The current period calculation of Adjusted EPS includes stock based compensation expense.

•Second quarter orders, excluding Paragon & Certrec acquisitions, were $229 million, a 10% increase from $208 million in the same period last year. Including Paragon and Certrec acquisitions, second quarter orders were $291 million, a 40% increase compared to the same period last year.

•The company reaffirmed 2026 total revenue growth, Organic Revenue growth, Adjusted EBITDA, Adjusted Free Cash Flow, and Adjusted EPS guidance for the fiscal year ending December 31, 2026.

Atlanta, GA – July 28, 2026 – Mirion (“we” or the “company”) (NYSE: MIR), a global provider of radiation detection, measurement, analysis, and monitoring solutions to the nuclear, medical, defense, and research end markets, today announced results for the second quarter ended June 30, 2026.

“Our second quarter performance reflects margin expansion across both operating segments, increased adjusted free cash flow, and continued orders and backlog growth,” commented Mirion’s Chairman and Chief Executive Officer Thomas Logan. “We captured several large opportunity orders in the second quarter with substantial opportunity available for the rest of the year.”

Logan continued, “Our acquisitions of Certrec and Paragon have augmented our ability to capitalize on growing nuclear power opportunities in North America. Moreover, our global presence puts us at the forefront of international nuclear growth ambitions.”

2026 Guidance

Commenting on Mirion’s full year 2026 guidance, Logan said, “We remain well-positioned for second half 2026 accelerated revenue growth, adjusted free cash flow, and margin expansion. We are maintaining our full year 2026 guidance while adjusting the end-market composition of our Medical segment.”

Mirion reaffirmed 2026 total revenue growth, Organic Revenue growth, Adjusted EBITDA, Adjusted Free Cash Flow, and Adjusted EPS guidance for the fiscal year ending December 31, 2026.

•Revenue growth of approximately 22.0% – 24.0%; includes foreign exchange rate and acquisition-related tailwinds.

•Organic Revenue growth of approximately 5.0% – 7.0%.

•Adjusted EBITDA and Adjusted EBITDA margin of approximately $285 million – $300 million; Adjusted EBITDA margin of approximately 25.0% – 26.0%.

•Adjusted Free Cash Flow of approximately $155 million – $175 million; Adjusted Free Cash Flow Conversion of approximately 54% – 58% of Adjusted EBITDA.

•Adjusted EPS of approximately $0.48 – $0.55 per share.

Exhibit 99.1

News Release

Additional modeling and guidance assumptions are included in the appendix of the earnings presentation on the Company’s investor relations page.

The Company’s guidance contains forward-looking statements and actual results may differ materially as a result of known and unknown uncertainties and risks, including those set forth below under the heading “Forward-Looking Statements.” In addition, forward-looking non-GAAP financial measures are presented on a non-GAAP basis without reconciliations of such forward-looking non-GAAP measures due to the inherent difficulty in projecting and quantifying the various adjusting items necessary for such reconciliations, such as stock-based compensation expense, amortization and depreciation expense, merger and acquisition activity and purchase accounting adjustments, that have not yet occurred, are out of Mirion’s control, or cannot be reasonably predicted. Accordingly, reconciliations of our guidance for Organic Revenue growth, Adjusted EBITDA, Adjusted EBITDA margin, Adjusted EPS, Adjusted Free Cash Flow and Adjusted Free Cash Flow conversion are not available without unreasonable effort.

Conference Call

Mirion will host a conference call tomorrow, July 29, 2026 at 10:00 a.m. ET to discuss its financial results. Participants may access the call by dialing 1-877-407-9208 or 1-201-493-6784, and requesting to join the Mirion Technologies, Inc. earnings call. A live webcast will also be available at https://ir.mirion.com/news-events.

A telephonic replay will be available shortly after the conclusion of the call and until August 12, 2026. Participants may access the replay at 1-844-512-2921 or 1-412-317-6671, and enter access code 13761513. An a

EX-99.1

2 a2026-04x28exhibit991.htm

EX-99.1

Document

Exhibit 99.1

News Release

Mirion Announces First Quarter 2026 Financial Results

•Revenues for the first quarter increased 27.5% to $257.6 million, compared to $202.0 million in the same period in 2025.

•GAAP net loss was $3.4 million in the first quarter, compared to GAAP net income of $0.4 million in the same period in 2025; Adjusted EBITDA was $54.3 million in the first quarter, a 16.3% increase from $46.7 million in the same period last year.

•GAAP net loss per share in the first quarter was $0.01, compared to a GAAP net earnings per share of $0.00 in the same period in 2025. Adjusted earnings per share for the quarter was $0.10, compared to $0.10 in the same period in 2025. The calculation for adjusted earnings per share has been adjusted for the current period to include stock-based compensation.

•First quarter orders, excluding Paragon & Certrec acquisitions, were $241 million, a 19% increase from $203 million in the same period last year. Including Paragon and Certrec acquisitions, first quarter orders were $288 million, a 42% increase compared to the same period last year.

•The company reaffirmed 2026 total revenue growth, Organic Revenue growth, Adjusted EBITDA, and Adjusted Free Cash Flow guidance for the fiscal year ending December 31, 2026, while revising Adjusted EPS guidance to reflect the impact of a special one-time CEO retention grant of performance vesting stock options disclosed on April 13, 2026.

Atlanta, GA – April 28, 2026 – Mirion (“we” or the “company”) (NYSE: MIR), a global provider of radiation detection, measurement, analysis, and monitoring solutions to the nuclear, medical, defense, and research end markets, today announced results for the first quarter ended March 31, 2026.

“Our first quarter performance showcased substantial orders growth led by nuclear power demand and as-expected Adjusted EBITDA performance and margins,” commented Mirion’s Chairman and Chief Executive Officer Thomas Logan. “Record capital spending commitments by power plant operators are driving accelerating momentum in the sector, which is translating into significant Nuclear Power demand.”

Logan continued, “Our strong performance also reflects Paragon’s contributions in its first full quarter with Mirion. Paragon is the ‘tip of the spear’ for growing installed base dynamics. Integration is on-pace, and we are already realizing commercial synergies.”

2026 Guidance

Commenting on Mirion’s full year 2026 guidance, Logan said, “We remain on track for 2026 revenue growth, Organic Revenue growth, Adjusted EBITDA, and Adjusted Free Cash Flow guidance. Our business continues to capture momentum in Nuclear Power and Cancer Care markets. Additionally, we are bringing new products to market and enhancing our current offerings to meet customers where they are headed.”

Mirion reaffirmed 2026 total revenue growth, Organic Revenue growth, Adjusted EBITDA, and Adjusted Free Cash Flow guidance for the fiscal year ending December 31, 2026, while revising Adjusted EPS guidance to reflect the impact of a special one-time CEO retention grant of performance vesting stock options disclosed on April 13, 2026.

•Revenue growth of approximately 22.0% – 24.0%; includes foreign exchange rate and acquisition-related tailwinds.

•Organic Revenue growth of approximately 5.0% – 7.0%.

•Adjusted EBITDA and Adjusted EBITDA margin of approximately $285 million – $300 million; Adjusted EBITDA margin of approximately 25.0% – 26.0%.

Exhibit 99.1

News Release

•Adjusted Free Cash Flow of approximately $155 million – $175 million; Adjusted Free Cash Flow Conversion of approximately 54% – 58% of Adjusted EBITDA.

•Adjusted EPS of approximately $0.48 – $0.55 per share (previously $0.50 – $0.57 per share); adjusted to reflect the impact of a special one-time CEO retention grant of performance vesting stock options disclosed on April 13, 2026.

Additional modeling and guidance assumptions are included in the appendix of the earnings presentation on the Company’s investor relations page.

The Company’s guidance contains forward-looking statements and actual results may differ materially as a result of known and unknown uncertainties and risks, including those set forth below under the heading “Forward-Looking Statements.” In addition, forward-looking non-GAAP financial measures are presented on a non-GAAP basis without reconciliations of such forward-looking non-GAAP measures due to the inherent difficulty in projecting and quantifying the various adjusting items necessary for such reconciliations, such as stock-based compensation expense, amortization and depreciation expense, merger and acquisition activity and purchase accounting adjustments, that have not yet occurred, are out of Mirion’s control, or cannot be reasonably predicted. Accordingly, reconciliations of our guidance for Organic Revenue growth, Adjusted EBITDA, Adjusted EBITDA margin, Adjusted EPS, Adjusted Free C

EX-99.1

2 a2026-02x10exhibit991.htm

EX-99.1

Document

Exhibit 99.1

News Release

Mirion Announces Fourth Quarter and Full Year 2025 Financial Results; Provides Full Year 2026 Guidance

•Revenues for the fourth quarter increased 9.1% to $277.4 million, compared to $254.3 million in the same period in 2024.

•GAAP net income was $17.8 million in the fourth quarter, compared to a GAAP net income of $15.9 million in the same period in 2024, an 11.9% improvement. Adjusted EBITDA was $77.6 million, an 11.5% increase from $69.6 million in the same period in 2024.

•GAAP net earnings per share in the fourth quarter was $0.07, compared to a GAAP net earnings per share of $0.07 in 2024. Adjusted earnings per share for the quarter was $0.15, compared to $0.17 in the same period in 2024.

•The company announced its full year 2026 guidance for revenue growth, Organic Revenue growth, Adjusted EBITDA, Adjusted Free Cash Flow, and Adjusted Earnings per Share.

◦Total Revenue growth rate is expected to be between 22.0% and 24.0%.

◦Organic Revenue growth rate is expected to be between 5.0% and 7.0%.

◦Adjusted EBITDA is expected to be between $285 million and $300 million.

◦Adjusted Free Cash Flow is expected to be between $155 and $175 million.

◦Adjusted Earnings per Share is expected to be between $0.50 and $0.57 per share, now including stock-based compensation.

Atlanta, GA – February 10, 2026 – Mirion (“we” or the “company”) (NYSE: MIR), a global provider of radiation detection, measurement, analysis, and monitoring solutions to the nuclear, medical, defense, and research end markets, today announced results for the fourth quarter and full year ended December 31, 2025.

“Mirion concluded another successful year, highlighted by record orders, strong tailwinds from key strategic end-markets, and a broadening nuclear power portfolio,” commented Mirion’s Chairman and Chief Executive Officer Thomas Logan. “In addition, we delivered on our Adjusted EBITDA and our Adjusted Free Cash Flow targets.”

Logan continued, “We booked over $1 billion of orders in 2025, including approximately $150 million from the large opportunity pipeline previously foreshadowed. Importantly, these orders reflect growth from all three Nuclear Power verticals: new utility scale reactors, the installed base, and small modular reactors. We continue to expect meaningful order growth in 2026, including full-year contributions from Paragon Energy Solutions and Certrec.”

2026 Guidance

Commenting on Mirion’s full year 2026 guidance, Logan said, “2026 guidance reflects strong market fundamentals supporting growing revenue, expanding margins, and enhancing Adjusted Free Cash Flow generation.”

Mirion has provided the following guidance for the fiscal year ending December 31, 2026.

•Revenue growth of approximately 22.0% – 24.0%; includes a foreign exchange rate and acquisition-related tailwinds

•Organic Revenue growth of approximately 5.0% – 7.0%

•Adjusted EBITDA of approximately $285 million – $300 million; Adjusted EBITDA margin of approximately 25.0% – 26.0%

Exhibit 99.1

News Release

•Adjusted Free Cash Flow of approximately $155 million – $175 million; Adjusted Free Cash Flow Conversion of approximately 54% – 58% of Adjusted EBITDA

•Adjusted EPS of approximately $0.50 – $0.57 per share; now including stock-based compensation

Additional modeling and guidance assumptions are included in the earnings presentation on the Company’s investor relations page.

The Company’s guidance contains forward-looking statements and actual results may differ materially as a result of known and unknown uncertainties and risks, including those set forth below under the heading “Forward-Looking Statements.” In addition, forward-looking non-GAAP financial measures are presented on a non-GAAP basis without reconciliations of such forward-looking non-GAAP measures due to the inherent difficulty in projecting and quantifying the various adjusting items necessary for such reconciliations, such as stock-based compensation expense, amortization and depreciation expense, merger and acquisition activity and purchase accounting adjustments, that have not yet occurred, are out of Mirion’s control, or cannot be reasonably predicted. Accordingly, reconciliations of our guidance for organic revenue growth, adjusted EBITDA, adjusted EPS, adjusted free cash flow and adjusted free cash flow conversion are not available without unreasonable effort.

Conference Call

Mirion will host a conference call tomorrow, February 11, 2026 at 11:00 a.m. ET to discuss its financial results. Participants may access the call by dialing 1-877-407-9208 or 1-201-493-6784, and requesting to join the Mirion Technologies, Inc. earnings call. A live webcast will also be available at https://ir.mirion.com/news-events.

A telephonic replay will be available shortly after the conclusion of the call and until February 25, 2026. Participants may access the replay at 1-844-512-2921 or 1-412-317-6671, and e